Consistent with these concepts, mouse pancreatic cancer cells gaining plasticity through GATA6 loss increased their chemoresistance and ability to escape immune elimination (29), and tumors able to switch subtypes through the expression of the GLI2 transcription factor have shorter survival and higher tumor growth rates (30). This evidence concerns the gene GATA6 and familial pancreatic carcinoma.